Molecular Partners AG
MOLN· Nasdaq
Who holds Molecular Partners AG, from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Montanova Capital, LLC | 2.2M | ±0% | $8.7M | 0.2% | Nov 16, 2026 |
| BVF Inc | 1.4M | ±0% | $5.2M | 0.2% | Nov 16, 2026 |
| Citadel Advisors LLC | 12.4K | −28.0% | $47.4K | 0% | Nov 16, 2026 |
| Morgan Stanley | 367 | ±0% | $1.4K | 0% | Nov 13, 2026 |
| UBS Group AG | 151 | −45.9% | $590 | 0% | Nov 10, 2026 |
| Tower Research Capital LLC (TRC) | 45 | New | $176 | 0% | Nov 16, 2026 |
| JPMorgan Chase & Co | 15 | New | $61 | 0% | Nov 12, 2026 |